nilotinib hydrochloride dihydrate
SpainDrugs containing this active substance
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children.
Form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 170,54 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children.
Form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 227,38 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when other treatments have not worked or have caused serious side effects.
Form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 170,54 mg Manufacturer: Teva Gmbh
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when previous treatments have not worked or have caused serious side effects.
Form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 227,38 mg Manufacturer: Teva Gmbh